Unlock instant, AI-driven research and patent intelligence for your innovation.

Radix angelicae sinensis blood enriching decoction and application of effective component astragaloside thereof to preparation of medicine for treating alcoholic liver disease

A technology of alcoholic liver disease and astragaloside IV, applied in the field of medicine, can solve problems such as promoting hepatic steatosis and harmful inflammation

Inactive Publication Date: 2021-07-06
贵州中医药大学
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Thus, activation of NF-κB signaling may lead to deleterious inflammation and promote hepatic steatosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Radix angelicae sinensis blood enriching decoction and application of effective component astragaloside thereof to preparation of medicine for treating alcoholic liver disease
  • Radix angelicae sinensis blood enriching decoction and application of effective component astragaloside thereof to preparation of medicine for treating alcoholic liver disease
  • Radix angelicae sinensis blood enriching decoction and application of effective component astragaloside thereof to preparation of medicine for treating alcoholic liver disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Effect of Danggui Buxue Decoction and Astragaloside IV on ALD Rat Liver Tissue Fat Metabolism

[0042] 1.1 Materials and methods

[0043] Preparation of Danggui Buxue Decoction: Weigh the crude drug according to the compatibility ratio of Astragalus and Angelica 5:1, add 10 times the amount of cold water to soak for 30 minutes, start decocting with strong fire, after boiling, decoct with slow fire for 40 minutes, filter while it is hot, and the filtrate will drip naturally do. Add 6 times the amount of water for the second decoction, the decoction method is the same as above, and combine the filtrate. Concentrate by rotary evaporation in a rotary evaporator at a constant temperature of 60°C to a concentration of 1g / m1, and store in a refrigerator at 4°C for later use.

[0044] Preparation of ALD rat model: 40 SPF grade male SD rats, weighing between 200±20g. Rats were randomly divided into blank group, model group, Danggui Buxue Decoction group, and astraga...

Embodiment 2

[0055] Example 2 Effects of Danggui Buxue Decoction and Astragaloside IV on liver tissue cell apoptosis, oxidative stress, and inflammatory pathways and factors in ALD rats

[0056] 2.1 Materials and methods

[0057] The same as the materials and methods under "1.1". The liver tissue preserved in liquid nitrogen was taken out and ground into powder. Operate according to the kit instructions and detect relevant indicators.

[0058] 2.2 Grouping

[0059] They were randomly divided into 7 groups: normal group, model group, Danggui Buxue Decoction group (3.5g / kg / d), astragaloside IV group (25μg / kg / d), 10 rats in each group.

[0060] 2.3 Detection and indicators

[0061] ① TUNEL staining to observe cell apoptosis in liver tissue.

[0062] ②ELISA: ROS, SOD.

[0063] ③RT-qPCR: TNF-α, IL-10; PPARγ.

[0064] ④Western blot: Bax, Bcl-2, ATP, CYP2E1, NF-κB.

[0065] 2.4 Results

[0066] The experimental results showed that: compared with the blank group, the rat liver tissue apopto...

Embodiment 3

[0068] Example 3 Effect of Astragaloside IV on Ethanol-Induced AML-12 Cell Lipid Metabolism, Inflammation and Oxidative Stress

[0069] 3.1 Materials and methods

[0070] AML-12 hepatocytes were cultured in a cell culture incubator at 37°C and 5% CO2 using a medium containing 10% fetal bovine serum. AML-12 cells were treated with 50, 75, 100, 150 or 200 mM ethanol and 50, 75, 100, 150 or 200 μg / mL astragaloside IV for 48 hours, respectively. Then, the cells were collected to analyze the cell viability by MTT method. Select 200mM ethanol and 200μg / mL astragaloside IV for subsequent determination. Untreated and ethanol-treated AML-12 cells were used as controls. The liver cell line AML-12 was purchased from the Type Culture Collection Center of the Chinese Academy of Sciences (Shanghai, China), and the cell culture reagents were purchased from Thermo Fisher Scientific (Massachusetts, USA).

[0071] 3.2 Grouping

[0072] Blank group, model group (200mM ethanol), astragalosid...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a radix angelicae sinensis blood enriching decoction and application of effective component astragaloside thereof to preparation of a medicine for treating an alcoholic liver disease. The radix angelicae sinensis blood enriching decoction and the astragaloside of the invention reduce lipid accumulation and inflammations in livers in rat and cell models, inhibit liver cell apoptosis and improve liver functions; and the radix angelicae sinensis blood enriching decoction and the astragaloside can inhibit alcohol-induced reactive oxygen species (ROS) generation and oxidative stress reaction in the liver, and accordingly, functions of the radix angelicae sinensis blood enriching decoction and astragaloside are exerted, the pharmacological mechanism of the radix angelicae sinensis blood enriching decoction to preparation of the medicine for treating the alcoholic liver disease is clarified, and a potential preparation treatment strategy is provided for the alcoholic liver disease (ALD).

Description

technical field [0001] The invention relates to the field of medical inventions, in particular to the application of Danggui Buxue Decoction and its active ingredient, astragaloside IV, in the preparation of drugs for treating alcoholic liver disease. Background technique [0002] Alcoholic liver disease (ALD) refers to chronic liver disease manifested by alcoholic fatty liver, alcoholic hepatitis, alcoholic liver fibrosis or alcoholic liver cirrhosis caused by long-term drinking. It is the main cause of liver cirrhosis in western countries, and it has become one of the most important chronic liver diseases in my country, and its incidence is still increasing year by year. Its pathogenesis is not very clear, and it may be closely related to the toxic effect of alcohol metabolites on the liver, oxidative stress, immune response, gene polymorphism, etc. Up to now, the FDA has not approved any effective drug for the treatment of ALD. Therefore, the research on the pathogenesis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/481A61K31/7048A61P1/16A61K36/232
CPCA61K31/7048A61K36/232A61K36/481A61K2236/331A61K2236/39A61K2236/51A61P1/16A61K2300/00
Inventor 蒋志滨高洁陈云志柴艺汇李文罗运凤张旭飞
Owner 贵州中医药大学